---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-139580"
form_type: "8-K"
ticker: "BOLT"
cik: "0001641281"
company_name: "Bolt Biotherapeutics, Inc."
filed_at: "2024-12-23T23:59:59+00:00"
generated_at: "2026-05-28T23:38:22.495399+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Director Mahendra Shah resigns from Bolt Biotherapeutics board; Dupont added to two committees

## Summary
- Dr. Mahendra Shah notified his resignation on Dec 19, effective Dec 31, 2024, for personal reasons.
- Shah's departure not due to any disagreement with the company's operations, policies, or practices.
- Board appointed existing director Dr. Jakob Dupont to the Audit Committee and Nominating and Corporate Governance Committee, effective upon Shah's resignation.

## SEC filing metadata
- accession: 0000950170-24-139580
- form_type: 8-K
- ticker: BOLT
- cik: 0001641281
- company_name: Bolt Biotherapeutics, Inc.
- filed_at: 2024-12-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641281/000095017024139580/0000950170-24-139580-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641281/000095017024139580/bolt-20241223.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-139580
- JSON: https://secwatch.observer/filing/0000950170-24-139580.json
- Plain text: https://secwatch.observer/filing/0000950170-24-139580.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.